Ocumetics Technology Corp (TSE:OTC) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Ocumetics Technology Corp has successfully completed the first part of its private placement, raising CA$2.82 million through the issuance of secured convertible debentures. These funds are earmarked primarily for the company’s inaugural in-human clinical trials and ongoing R&D. The debentures, bearing an 18% annual interest rate, allow holders to convert their debt into common shares at $0.32 each.
For further insights into TSE:OTC stock, check out TipRanks’ Stock Analysis page.